Advertisement

Psychopharmacology

, Volume 221, Issue 1, pp 67–77 | Cite as

Imaging human reward processing with positron emission tomography and functional magnetic resonance imaging

  • Nina B. L. UrbanEmail author
  • Mark Slifstein
  • Shashwath Meda
  • Xiaoyan Xu
  • Rawad Ayoub
  • Olga Medina
  • Godfrey D. Pearlson
  • John H. Krystal
  • Anissa Abi-Dargham
Original Investigation

Abstract

Functional neuroimaging (fMRI) studies show activation in mesolimbic circuitry in tasks involving reward processing, like the Monetary Incentive Delay Task (MIDT). In voltammetry studies in animals, mesolimbic dopamine release is associated with reward salience. This study examined the relationship between fMRI activation and magnitude of dopamine release measured with Positron emission tomography study (PET) in the same subjects using MIDT in both modalities to test if fMRI activation is related to dopamine release. Eighteen healthy subjects were scanned with [11 C]raclopride PET at baseline and after MIDT. Binding potential (BPND) was derived by equilibrium analysis in striatal subregions and percent change across conditions (∆BPND) was measured. Blood oxygen level dependence (BOLD) signal changes with MIDT were measured during fMRI using voxelwise analysis and ROI analysis and correlated with ∆BPND. ∆BPND was not significant in the ventral striatum (VST) but reached significance in the posterior caudate. The fMRI BOLD activation was highest in VST. No significant associations between ∆BPND and change in fMRI BOLD were observed with VST using ROI analysis. Voxelwise analysis showed positive correlation between BOLD activation in anticipation of the highest reward and ∆BPND in VST and precommissural putamen. Our study indicates that endogenous dopamine release in VST is of small magnitude and is related to BOLD signal change during performance of the MIDT in only a few voxels when rewarding and nonrewarding conditions are interspersed. The lack of correlation at the ROI level may be due to the small magnitude of release or to the particular dependence of BOLD on glutamatergic signaling.

Keywords

Human reward processing Dopamine MIDT PET fMRI 

Notes

Acknowledgements

We would like to thank Mr. Ben Gunter for technical support with the fMRI arm of the study. This research was carried out at New York State Psychiatric Institute/Columbia University Medical Center under a subcontract from the Center for Translational Neuroscience of Alcoholism at Yale University, supported by grant number P50AA-012870-09 from the National Institute on Alcohol Abuse and Alcoholism. The funding agency had no role in the design and conduct of the study; in the collection, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript.

Financial disclosures: M. Slifstein: consultant: Amgen, GlaxoSmithKline; research support: Pierre Fabre, Inc.; J.H. Krystal reports the following: consultant: Aisling Capital, LLC, AstraZeneca Pharmaceuticals, Brintnall & Nicolini, Inc., Easton Associates, Gilead Sciences, Inc., GlaxoSmithKline, Janssen Pharmaceuticals, Lundbeck Research USA, Medivation, Inc., Merz Pharmaceuticals, MK Medical Communications, F. Hoffmann-La Roche Ltd., SK Holdings Co., Ltd., Takeda Industries, Teva Pharmaceutical Industries, Ltd.; scientific advisory board: Abbott Laboratories, Bristol-Myers Squibb, Eisai, Inc., Eli Lilly and Co., Lohocla Research Corporation, Naurex, Inc., Pfizer Pharmaceuticals Exercisable Warrant Options (value less than $500): Tetragenex Pharmaceuticals; research/study drug support: Janssen Research Foundation (to the Department of Veterans Affairs); Board of Directors: Coalition for Translational Research in Alcohol and Substance Use Disorders, American College of Neuropsychopharmacology (President elect); Editor: Biological Psychiatry; inventions: 1) Seibyl JP, Krystal JH, Charney DS. Dopamine and noradrenergic reuptake inhibitors in treatment of schizophrenia. Patent #: 5,447,948. September 5, 1995; 2) coinventor with Dr. Gerard Sanacora on a filed patent application by Yale University related to targeting the glutamatergic system for the treatment of neuropsychiatric disorders (PCTWO06108055A1); and 3) Intranasal Administration of Ketamine to Treat Depression (pending). A. Abi-Dargham: Bristol-Myers Squibb-Otsuka (consultant and speaker), Bohringer-Engelheim, Lundbeck, Sepracor, Merck (consultant), GlaxoSmithKline (research grant). All other authors reported no biomedical financial interests or potential conflicts of interest.

References

  1. Aarts E, Roelofs A et al (2010) Striatal dopamine mediates the interface between motivational and cognitive control in humans: evidence from genetic imaging. Neuropsychopharmacology 35(9):1943–1951PubMedCrossRefGoogle Scholar
  2. Andrews MM, Meda SA, et al. ( 2010). Individuals family history positive for alcoholism show functional magnetic resonance imaging differences in reward sensitivity that are related to impulsivity factors. Biol Psychiatry(Nov 30.): [Epub ahead of print].Google Scholar
  3. Arias-Carrion O, Poppel E (2007) Dopamine, learning, and reward-seeking behavior. Acta Neurobiol Exp (Wars) 67(4):481–488Google Scholar
  4. Ashburner J (2009) Computational anatomy with the SPM software. Magn Reson Imaging 27(8):1163–1174PubMedCrossRefGoogle Scholar
  5. Bayer HM, Glimcher PW (2005) Midbrain dopamine neurons encode a quantitative reward prediction error signal. Neuron 47(1):129–141PubMedCrossRefGoogle Scholar
  6. Boileau I, Dagher A et al (2007) Conditioned dopamine release in humans: a positron emission tomography [11 C]raclopride study with amphetamine. J Neurosci 27(15):3998–4003PubMedCrossRefGoogle Scholar
  7. Cools R, Frank MJ et al (2009) Striatal dopamine predicts outcome-specific reversal learning and its sensitivity to dopaminergic drug administration. J Neurosci 29(5):1538–1543PubMedCrossRefGoogle Scholar
  8. D'Ardenne K, McClure SM et al (2008) BOLD responses reflecting dopaminergic signals in the human ventral tegmental area. Science 319(5867):1264–1267PubMedCrossRefGoogle Scholar
  9. First MB, Spitzer RL et al (1995) Structured clinical interview for DSM-IV axis I disorders. Biometrics Research, New York State Psychiatric Institute, New YorkGoogle Scholar
  10. Fujiwara J, Tobler PN et al (2009) Segregated and integrated coding of reward and punishment in the cingulate cortex. J Neurophysiol 6(101):3284–3293CrossRefGoogle Scholar
  11. Garris PA, Kilpatrick M et al (1999) Dissociation of dopamine release in the nucleus accumbens from intracranial self-stimulation. Nature 398:67–69PubMedCrossRefGoogle Scholar
  12. Goerendt IK, Messa C et al (2003) Dopamine release during sequential finger movements in health and Parkinson's disease: a PET study. Brain 126(Pt 2):312–325PubMedCrossRefGoogle Scholar
  13. Haber SN, Fudge JL et al (2000) Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum. J Neurosci 20(6):2369–2382PubMedGoogle Scholar
  14. Hakyemez HS, Dagher A et al (2008) Striatal dopamine transmission in healthy humans during a passive monetary reward task. NeuroImage 39(4):2058–2065PubMedCrossRefGoogle Scholar
  15. Hall H, Sedvall G et al (1994) Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain. Neuropsychopharmacology 11(4):245–256PubMedCrossRefGoogle Scholar
  16. Knutson B, Westdorp A et al (2000) FMRI visualization of brain activity during a monetary incentive delay task. NeuroImage 12(1):20–27PubMedCrossRefGoogle Scholar
  17. Knutson B, Adams CM et al (2001a) Anticipation of increasing monetary reward selectively recruits nucleus accumbens. J Neurosci 21(16):RC159PubMedGoogle Scholar
  18. Knutson B, Fong GW et al (2001b) Dissociation of reward anticipation and outcome with event-related fMRI. Neuroreport 12(17):3683–3687PubMedCrossRefGoogle Scholar
  19. Knutson B, Taylor J et al (2005) Distributed neural representation of expected value. J Neurosci 25(19):4806–4812PubMedCrossRefGoogle Scholar
  20. Koepp MJ, Gunn RN et al (1998) Evidence for striatal dopamine release during a video game. Nature 393(6682):266–268PubMedCrossRefGoogle Scholar
  21. Lappin JM, Reeves SJ et al (2009) Dopamine release in the human striatum: motor and cognitive tasks revisited. J Cereb Blood Flow Metab 29(3):554–564PubMedCrossRefGoogle Scholar
  22. Laruelle M (2000) Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J Cereb Blood Flow Metab 20(3):423–451PubMedCrossRefGoogle Scholar
  23. Laruelle M, Abi-Dargham A et al (1994) SPECT quantification of [123I]iomazenil binding to benzodiazepine receptors in nonhuman primates: II. Equilibrium analysis of constant infusion experiments and correlation with in vitro parameters. J Cereb Blood Flow Metab 14(3):453–465PubMedCrossRefGoogle Scholar
  24. Lidstone SC, Schulzer M et al (2010) Effects of expectation on placebo-induced dopamine release in Parkinson disease. Arch Gen Psychiatry 67(8):857–865PubMedCrossRefGoogle Scholar
  25. Martinez D, Slifstein M et al (2003) Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum. J Cereb Blood Flow Metab 23(3):285–300PubMedCrossRefGoogle Scholar
  26. Martinez D, Gil R et al (2005) Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum. Biol Psychiatry 58(10):779–786PubMedCrossRefGoogle Scholar
  27. Martin-Soelch C, Szczepanik J et al (2011) Lateralization and gender differences in the dopaminergic response to unpredictable reward in the human ventral striatum. Eur J Neurosci 33(9):1706–1715PubMedCrossRefGoogle Scholar
  28. Mawlawi O, Martinez D et al (2001) Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum. J Cereb Blood Flow Metab 21(9):1034–1057PubMedCrossRefGoogle Scholar
  29. Ouchi Y, Yoshikawa E et al (2002) Effect of simple motor performance on regional dopamine release in the striatum in Parkinson disease patients and healthy subjects: a positron emission tomography study. J Cereb Blood Flow Metab 22(6):746–752PubMedCrossRefGoogle Scholar
  30. Pessiglione M, Seymour B et al (2006) Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans. Nature 442(7106):1042–1045PubMedCrossRefGoogle Scholar
  31. Rademacher L, Krach S et al (2010) Dissociation of neural networks for anticipation and consumption of monetary and social rewards. NeuroImage 49(4):3276–3285PubMedCrossRefGoogle Scholar
  32. Richardson NR, Gratton A (1996) Behavior-relevant changes in nucleus accumbens dopamine transmission elicited by food reinforcement: an electrochemical study in rat. J Neurosci 16:8160–8169PubMedGoogle Scholar
  33. Schott BH, Niehaus L et al (2007) Ageing and early-stage Parkinson's disease affect separable neural mechanisms of mesolimbic reward processing. Brain 130(Pt 9):2412–2424PubMedCrossRefGoogle Scholar
  34. Schott BH, Minuzzi L et al (2008) Mesolimbic functional magnetic resonance imaging activations during reward anticipation correlate with reward-related ventral striatal dopamine release. J Neurosci 28(52):14311–14319PubMedCrossRefGoogle Scholar
  35. Schultz W (1998) Predictive reward signal of dopamine neurons. J Neurophysiol 80(1):1–27PubMedGoogle Scholar
  36. Schultz W, Apicella P et al (1992) Neuronal activity in monkey ventral striatum related to the expectation of reward. J Neurosci 12(12):4595–4610PubMedGoogle Scholar
  37. Schultz W, Dayan P et al (1997) A neural substrate of prediction and reward. Science 275:1593–1599PubMedCrossRefGoogle Scholar
  38. Schultz W, Tremblay L et al (2000) Reward processing in primate orbitofrontal cortex and basal ganglia. Cereb Cortex 10(3):272–284PubMedCrossRefGoogle Scholar
  39. Scott DJ, Stohler CS et al (2007) Individual differences in reward responding explain placebo-induced expectations and effects. Neuron 55(2):325–336PubMedCrossRefGoogle Scholar
  40. Shulman RG, Hyder F, Rothman DL (2002) Biophysical basis of brain activity: implications for neuroimaging. Q Rev Biophys 35(3):287–325PubMedCrossRefGoogle Scholar
  41. Small DM, Jones-Gotman M et al (2003) Feeding-induced dopamine release in dorsal striatum correlates with meal pleasantness ratings in healthy human volunteers. NeuroImage 19(4):1709–1715PubMedCrossRefGoogle Scholar
  42. Sutton, R. S. and A. G. Barto (1998). Reinforcement learning: an introduction adaptive computation and machine learning, The MIT Press. 3.Google Scholar
  43. Volkow ND, Wang GJ et al (2006) Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J Neurosci 26(24):6583–6588PubMedCrossRefGoogle Scholar
  44. Zald DH, Boileau I et al (2004) Dopamine transmission in the human striatum during monetary reward tasks. J Neurosci 24(17):4105–4112PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Nina B. L. Urban
    • 1
    • 8
    Email author
  • Mark Slifstein
    • 1
    • 3
    • 4
  • Shashwath Meda
    • 2
  • Xiaoyan Xu
    • 1
  • Rawad Ayoub
    • 1
  • Olga Medina
    • 1
  • Godfrey D. Pearlson
    • 5
    • 6
  • John H. Krystal
    • 5
    • 7
  • Anissa Abi-Dargham
    • 1
    • 3
    • 4
  1. 1.Department of Psychiatry at Columbia UniversityNew YorkUSA
  2. 2.Center for Human Genetics and Research, Vanderbilt UniversityNashvilleUSA
  3. 3.Radiology at Columbia UniversityNew YorkUSA
  4. 4.New York State Psychiatric InstituteNew YorkUSA
  5. 5.Department of Psychiatry at Yale UniversityNew HavenUSA
  6. 6.Olin Neuropsychiatry Research Center, Institute of LivingHartfordUSA
  7. 7.VA Alcohol Research Center, VA Connecticut Healthcare SystemWest HavenUSA
  8. 8.NYSPI, Department of PsychiatryNew YorkUSA

Personalised recommendations